Ngai Hang Victor Chong - 18 Mar 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLSD	Employee Stock Option (right to buy)	Award	$0	+450,000		$0.000000	450,000	18 Mar 2024	Common Stock	450,000	$1.56	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-fourth of the shares underlying this option vest on March 18, 2025 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.